International Stem Cell Corporation
ISCO · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 16.6% | -4.8% | 14% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 58.6% | 59.2% | 60% | 59.1% |
| EBITDA | $0 | $0 | $0 | -$0 |
| % Margin | 1.6% | 2.6% | 0.3% | -3.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2.3% | -1.7% | -5.7% | -14.5% |
| EPS Diluted | -0.026 | -0.016 | -0.058 | -0.13 |
| % Growth | -59.1% | 71.8% | 55.2% | – |
| Operating Cash Flow | $0 | $0 | $0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | $0 | -$0 |